Evidence map›Paper›PMID 35634584›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2022

Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection.

Sehoon Park, Seung-Hee Yang, Jiyeon Kim, Semin Cho, Jaeseok Yang, Sang-Il Min, Jongwon Ha, Chang Wook Jeong, Seong Hee Bhoo, Yong Chul Kim and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Sehoon ParkDepartment of Internal Medicine, Armed Forces Capital Hospital, Seongnam-si, South Korea.
Seung-Hee YangKidney Research Institute, Seoul National University, Seoul, South Korea.
Jiyeon KimKidney Research Institute, Seoul National University, Seoul, South Korea.
Semin ChoDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Jaeseok YangTransplantation Center, Department of Surgery, Seoul National University Hospital, Seoul, South Korea.
Sang-Il MinTransplantation Center, Department of Surgery, Seoul National University Hospital, Seoul, South Korea.
Jongwon HaTransplantation Center, Department of Surgery, Seoul National University Hospital, Seoul, South Korea.
Chang Wook JeongDepartment of Urology, Seoul National University Hospital, Seoul, South Korea.
Seong Hee BhooDepartment of Genetic Engineering and Graduate School of Biotechnology, Kyung Hee University, Yongin-si, South Korea.
Yong Chul KimDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Dong Ki KimKidney Research Institute, Seoul National University, Seoul, South Korea.
Kook-Hwan OhDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Kwon Wook JooKidney Research Institute, Seoul National University, Seoul, South Korea.
Yon Su KimKidney Research Institute, Seoul National University, Seoul, South Korea.
Kyung Chul MoonDepartment of Pathology, Seoul National University Hospital, Seoul, South Korea.
Eun Young SongDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul, South Korea.
Hajeong LeeDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Government of the Republic of Korea · KRSeoul National University Hospital · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is important to determine the clinical significance of non-human leukocyte antigen (HLA) antibodies and their association with antibody-mediated rejection (ABMR) of kidney allografts. We collected post-transplant sera from 68 ABMR patients, 67 T-cell mediated rejection (TCMR) patients, and 83 control subjects without rejection, and determined the titers of 39 non-HLA antibodies including antibodies for angiotensin II receptor type I and MICA. We compared all these non-HLA antibody titers among the study groups. Then, we investigated their association with the risk of death-censored graft failure in ABMR cases. Among the antibodies evaluated, anti-collagen type I (

Indexed as

Graft RejectionKidney TransplantationAntibodiesCollagen Type IHumansKidneyAntibodiesCollagen Type Iantibody-mediated rejectiongraft failurekidneykidney transplantationnon-HLA antibody

Identifiers

PMID35634584
PMCPMC9131656
OpenAlexW4285741756

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.